Abstract
Objective(s):
The essential oil (EO) extracted from Cinnamomum verum leaves has been used as an antimicrobial agent for centuries. But its antifungal and antibiofilm efficacy is still not clearly studied. The objective of this research was to evaluate the in vitro antifungal and antibiofilm efficacy of C. verum leaf EO against C. albicans, C. tropicalis, and C. dubliniensis and the toxicity of EO using an in vitro model.
Materials and Methods:
The effect of EO vapor was evaluated using a microatmosphere technique. CLSI microdilution assay was employed in determining the Minimum Inhibitory (MIC) and Fungicidal Concentrations (MFC). Killing time was determined using a standard protocol. The effect of EO on established biofilms was quantified and visualized using XTT and Scanning Electron Microscopy (SEM), respectively. Post-exposure intracellular changes were visualized using Transmission Electron Microscopy (TEM). The toxicological assessment was carried out with the Human Keratinocyte cell line. The chemical composition of EO was evaluated using Gas Chromatography-Mass Spectrometry (GC-MS).
Results:
All test strains were susceptible to cinnamon oil vapor. EO exhibited MIC value 1.0 mg/ml and MFC value 2.0 mg/ml against test strains. The killing time of cinnamon oil was 6 hr. Minimum Biofilm Inhibitory Concentration (MBIC50) for established biofilms was <0.2 mg/ml for all test strains. SEM images exhibited cell wall damages, cellular shrinkages, and decreased hyphal formation of Candida. TEM indicated intracellular vacuolation, granulation, and cell wall damages. Cinnamon leaf oil caused no inhibition of HaCaT cells at any concentration tested. Eugenol was the abundant compound in cinnamon oil.
Conclusion:
C. verum EO is a potential alternative anti-Candida agent with minimal toxicity on the human host.
Key Words: Antifungal agent, Biofilms, Candida spp., Cinnamomum verum, Essential oil
Introduction
The use of medicinal plants as a treatment option is an ancient practice and continues in the modern world. Ancient Asians including Sri Lankans, Indians, and Japanese people especially used these phytochemicals as their therapeutic agents. The use of medicinal plants as therapeutic alternatives has helped many populations that do not have any access to novel treatments and drugs of high cost and low availability. So, the use of plants for the treatment of diseases/infections has been empirically employed worldwide. In the past few years, with scientific advances, more research was conducted to introduce new compounds with medicinal properties, allowing scientists to find new, effective, alternative medicinal compounds with low side effects (1-4).
Essential oils extracted from C. verum leaves and bark were used as antimicrobial agents for centuries. Though this plant has been shown to be of great economic and pharmaceutical-medicinal interest (5), proper evidence-based studies are not yet carried out to evaluate the efficacy of cinnamon oils as an antimicrobial therapeutic agent.
Biofilms are communities of microorganisms attached to a surface living in a matrix of extracellular material derived both from the cells themselves and from the environment. Those microorganisms are usually organized into a three-dimensional structure (6-8) in order to form this complex biofilm ecosystem. Many human microbial infections (more than 65%) are related to biofilm formation on implanted biomaterials and/or host surfaces (9, 10). Biofilms are more resistant to most available antimicrobials compared with planktonic counterpart. Thus, it is important to introduce alternative biofilm controlling and eradication strategies in order to treat biofilm infections (11).
Candida spp. causes many oral, non-oral, and device-associated biofilm infections including periodontitis, dental caries (12), and endocarditis (13), systemic candidiasis, superficial Candida skin infections, ear infections, genitourinary tract infections, central venous catheters, prosthetic heart valves, and urinary catheter associated infections (14-16). Some of these infections are serious life-threatening infections while some are non-invasive and non-life-threatening.
Although several in vitro microbiological studies with essential oil extracted from C. verum leaves show antimicrobial activities related to many bacterial species in the health care area, including those that exhibit multiple antimicrobial resistance, its antifungal and antibiofilm effects on Candida spp. are still not comprehensive.
Materials and Methods
Fungal strains
Three Candida type strains, C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 750), and C. dubliniensis (ATCC MYA-646) were used in this study. These strains were obtained from Microbiology and Immunology Area, Piracicaba Dental School, UNICAMP, Brazil.
The standard Candida stocks were maintained in 80% glycerol in an ultrafreezer at -80 °C. To reactivate stock organisms, they were subcultured in freshly prepared Saboraud Dextrose Agar (SDA, OXOID) culture medium and incubated aerobically at 37 °C for 24 hr.
The standard cell suspensions were prepared by adjusting the turbidity in accordance with the 0.5 McFarland scale, which was equivalent to the absorbance of 0.08–0.10 (600 nm) corresponding to 5×106 CFU/ml.
All experiments were done in triplicate on two different occasions.
Essential oil
The essential oil of C. verum leaves extracted using steam distillation was purchased from Romik Lanka Marketing Services, Moratuwa, Sri Lanka (WCC/3569). The C. verum essential oil was diluted to 32 mg/ml in Tween 80 (0.05%) solution and Roswell Park Memorial Institute (RPMI) 1640 buffered with MOPS (3-(N-morpholino) propane sulfonic acid) followed by sonication, 1 cycle of 20 sec for antimicrobial assays and in vitro cytotoxicity. (17).
Effect of C. verum leaf essential oil in the vapor phase
Effects of C. verum leaf essential oil in vapor phase on planktonic Candida cells were qualitatively determined using the microatmosphere method described by Şerban et al. (2011) (18).
Standard suspensions of all test strains were prepared as explained previously and SDA plates were inoculated separately using a sterile cotton swab. A sterile filter paper disc moistened with the working solution (100 µl) of EO was attached to the lid of the Petri dish. Plates were sealed with a piece of parafilm and incubated overnight at 37 °C aerobically. Control plates were prepared without filter paper disks. The presence or absence of growth inhibition of inoculated Candida on agar surface was observed after 24 hr incubation.
Determination of minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC)
According to Clinical and Laboratory Standards Institute (CLSI) M27-A3 (19), 100 µl/well of the two-fold dilutions of EO in RPMI 1640 with MOPS were prepared in 96-well polystyrene microtiter plates. Subsequently, 100 µl of the prepared standard fungal cell suspensions containing 1×106 cells/ml were added to the dilutions and incubated at 37 °C for 24 hr. The MIC point was determined by visual observation for the presence and absence of growth (turbidity of the suspensions).
MFC was defined as the lowest concentration of essential oil required to inhibit the fungal growth completely. For MFC determination, 5 μl of solutions from each well of the previous experiment was plated in freshly prepared SDA plates and incubated at 37 °C for 24 hr aerobically. The lowest concentration which did not show any Candida growth on the SDA surface after incubation was considered as MFC.
Negative control group (Growth control): 100 µl of RPMI 1640 instead of essential oil+standard cell suspension. Positive control group: 120 mg/ml chlorhexidine digluconate (Sigma-Aldrich, USA).
Killing time assay
One hundered µl of C. albicans (ATCC MYA-2876) (0.5×106 CFU/ml) was mixed with 100 µl of 1.0, 2.0, and 4.0 mg/ml of EO respectively to obtain the final EO concentrations of MIC (1 mg/ml), half of MIC (0.5 mg/ml), and twice the MIC (2 mg/ml or MFC). After different incubation time intervals (0, 1, 2, 3, 4, 5, 6, 12, and 24 hr) at 37 °C, 50 µl of each mixture was diluted in sterile normal saline, plated on SDA using a sterile glass spreader, and incubated at 37 °C for 24 hr. Colonies were counted and CFU/ml was plotted against time (20) after 24 hr incubation.
Negative control: test organisms without oil or reference antifungal agent. 120 mg/ml chlorhexidine digluconate: positive control.
Minimum biofilm inhibitory concentration (MBIC 50 )
A 96-well sterile flat-bottomed polystyrene microplate was seeded with 5×106 CFU/ml standard inoculum of each test organism (100 μl/well) followed by aerobic incubation for 24 hr at 37 °C. The plate was washed once with sterile Phosphate Buffered Saline (PBS), and 100 μl of the essential oil dilutions were added to the treatment wells separately. 100 μl of RPMI 1640 was added to the negative control wells instead of oil. The plate was then aerobically incubated for 24 hr at 37 °C. Biofilm viability was quantified using XTT assay (17, 21).
Minimum biofilm eradication concentration (MBEC)
The CFU assay was performed on EO-treated biofilms to detect the MBEC of the oil on established 24 hr mature biofilms after the 24 hr treatment with different concentrations of C. verum leaf oil, as explained previously (17).
Post-exposure architecture of established Candida biofilms (scanning electron microscopy (SEM)
For determination of post-exposure architectural properties of Candida biofilms, mature biofilms were established on sterile 10 mm diameter glass coverslips and treated with 0.5, 1.0, and 2.0 mg/ml EO dilutions in RPMI 1640 for 24 hr as explained in a previous experiment and processed to examine under SEM (1, 22).
Transmission electron microscopy (TEM) for determination of post-exposure cellular changes
To determine the effect of C. verum leaf oil on Candida cell structure, post-exposure cellular changes were visualized using a Transmission Electron Microscope (TEM) as follows.
Briefly, standard cell suspensions with 1×106 cell density were prepared in RPMI 1640. 1 ml of prepared suspensions were mixed with 9 ml of antifungal oil dilution in RPMI 1640 with the concentration of 10×MIC (10 mg/ml) separately (final EO concentration of the mixture was 1.0 mg/ml) and incubated at 37 °C for 24 hr aerobically. After incubation, the resulting cell suspension was centrifuged and the cell pellet was resuspended with the Karnovsky’s fixative for 18-24 hours at 4 °C. After fixation, the specimen was processed as explained previously by Kapoor et al. (2017) (23).
Cytotoxicity of C. verum leaf oil on human cells
Cytotoxicity of C. verum leaf EO on normal human keratinocyte cell line, HaCaT was determined by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) viability assay according to the protocol described by Zanette et al. (2011) (24).
Briefly, 96-well culture plates were seeded with cells (6.5×104 cells/ml and 100 µl/well) and incubated for 24 hr. Then the culture medium was replaced with fresh medium containing different concentrations of true cinnamon leaf EO. The treated plates were further incubated for 24 hr at 37 °C with 5% CO2. After the incubation, the viability of treated HaCat cells was quantified using an MTT assay (25).
Chemical analysis of the essential oil
The chemical analysis of C. verum essential oil was performed by using the following gas chromatography-mass spectrometry (CG-EM) analysis conditions.
HP-6890 gas chromatograph coupled with HP-5975 selective mass detector; HP-5MS Capillary Column (30 m×0.25 mm×0.25 µm); temperatures: injector (220 °C), detector (250 °C), column (60 °C ), 3 °C/min, 240 °C ; flow rate of carrier gas (highly dried He) of 1.0 ml/min.
Statistical analysis
Statistical analysis was carried out using the software, Statistical Package for Social Sciences (SPSS) version 16. Multiple means of more than three data sets were compared using one-way ANOVA and two-way ANOVA. The level of significance was taken at 5% (P<0.05).
Results
Anti-Candida effect of C. verum leaf oil vapor
The results for antifungal efficacy of true cinnamon leaf oil vapor against three Candida test strains are presented in Table 1. Presence of growth inhibition on the agar surface indicates the sensitivity of relevant microorganisms to the treatment (18). All Candida test strains exhibited growth inhibition on the agar surface which is indicator of antifungal activity of C. verum leaf EO vapor on planktonic Candida (Table 1).
Table 1.
Inhibition zones exhibited by planktonic test strains in the presence of working concentration (1.0 g/ml) of Cinnamomum verum leaf oil. All experiments were done in triplicate
| Organism | Presence (+) /Absence (-) of growth inhibition | Sensitive/Resistant | |
|---|---|---|---|
| C. albicans (ATCC 5314) | + | Sensitive | |
| C. tropicalis (ATCC 750) | + | Sensitive | |
| C. dubliniensis (ATCC MYA-646) | + | Sensitive | |
Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC)
The MIC and MFC values corresponding to C. verum EO and the control antifungal chlorhexidine digluconate are represented in Table 2. C. verum exhibited similar efficacy as chlorhexidine digluconate on planktonic C. albicans (ATCC MYA-2876) and C. dubliniensis (ATCC MYA-646). C tropicalis (ATCC 750) was more susceptible for chlorhexidine digluconate compared with C. verum leaf oil. The emulsifier (Tween 80) did not affect the growth of the fungal strains at the used concentration. The MFC/MIC ratio showed that the C. verum leaf EO had a fungicidal effect on all three Candida species tested.
Table 2.
Results of MIC and MFC of Candida spp. The experiment was made in triplicates with three individual experiments. Chlorhexidine digluconate was used as a positive control
| Organism | Cinnamomum verum oil (mg/mL) | Chlorhexidine digluconate (mg/mL) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| MIC | MFC | MFC/MIC | MIC | MFC | MFC/MIC | ||||
|
C. albicans (ATCC 5314) |
1.0 | 2.0 | 2.0 | 1.0 | 2.0 | 2.0 | |||
|
C. tropicalis (ATCC 750) |
1.0 | 2.0 | 2.0 | 0.5 | 0.5 | 1.0 | |||
|
C. dubliniensis (ATCC MYA-646) |
1.0 | 2.0 | 2.0 | 1.0 | 2.0 | 2.0 | |||
Killing time assay
This experiment determined the minimum time required for true cinnamon leaf oil (or positive control chlorhexidine digluconate) to eradicate the viable planktonic Candida cells from their in vitro cultures. Killing curves for C. albicans (ATCC MYA-2876) were presented in Figure 1.
Figure 1.
Killing curves of Candida albicans (ATCC MYA-2876) for 0.5 mg/ml, 1.0 mg/ml, and 2 mg/ml C. verum leaf oil and 2.0 mg/ml chlorhexidine digluconate. Error bars are too small to indicate
CV: C. verum leaf oil, CHL: Chlorhexidine digluconate
According to obtained results, 0.5 mg/ml and 1.0 mg/ml C. verum leaf oil do not kill Candida cells completely within 24 hr test period, whereas 2.0 mg/ml kill Candida cells completely within 6 hr.
2.0 mg/ml chlorhexidine digluconate has a rapid killing action on Candida cells compared to true cinnamon leaf oil hence killing time was 1 hr.
Minimum biofilm inhibitory concentration (MBIC 50 )
Minimum concentrations of the essential oil required to reduce the biofilm cell viability by 50% of negative control biofilms (biofilms without treatments) were defined as MBIC50.
Figure 2 shows the percentage reduction of biofilm cell viability of 24 hr mature C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 750), and C. dubliniensis (ATCC MYA-646) biofilms determined by XTT viability assay after 24 hr treatment with C. verum leaf oil compared with the negative control (biofilms without treatment).
Figure 2.
Percentage reduction of XTT metabolic activity of Candida albicans (ATCC MYA-2876), C. tropicalis (ATCC 750), and C. dubliniensis (ATCC MYA-646) 24 hr established biofilms after treatment with different concentrations of Cinnamomum verum leaf oil (CV) and chlorhexidine digluconate (CHL). All error bars represent ± 2 standard deviations (SD)
According to obtained data from the XTT assay, concentrations required to reduce the biofilm viability by 50% are shown in Table 3.
Table 3.
Minimum biofilm inhibitory concentrations (MBIC50) for established biofilms of Candida albicans (ATCC MYA-2876), C. tropicalis (ATCC 750), and C. dubliniensis (ATCC MYA-646)
| C. albicans | C. tropicalis | C. dubliniensis | ||||
|---|---|---|---|---|---|---|
| C. verum | CHL | C. verum | CHL | C. verum | CHL | |
| MBIC50 (mg/mL) | 0.1 | 0.2 | 0.2 | 0.0625 | 0.2 | 0.3 |
CHL: Chlorhexidine digluconate
Minimum biofilm eradication concentration (MBEC)
The minimum concentration of C.verum leaf oil required to kill the 24 hr mature biofilm completely (MBEC) was determined using CFU assay. Figure 3 represents the viability of 24 hr mature biofilms after treating with different concentrations of C. verum leaf oil and chlorhexidine digluconate for 24 hr determined by CFU assay. Table 4 shows MBEC values for mature C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 750), and C. dubliniensis (ATCC MYA-646) biofilms.
Figure 3.
Mean Log CFU values of established Candida albicans (ATCC MYA-2876), C. tropicalis (ATCC 750), and C. dubliniensis (ATCC MYA-646) biofilms after 24 hr treatment with different concentrations of CV: Cinnamomum verum leaf oil and CHL: chlorhexidine digluconate All error bars represent the ± 2 standard deviations (SD)
Table 4.
Concentrations of Cinnamomum verum leaf oil and chlorhexidine digluconate that kill the established biofilms of Candida albicans (ATCC MYA-2876), C. tropicalis (ATCC 750), and C. dubliniensis (ATCC MYA646) completely (MBEC)
| Test strain | MBEC (mg/mL) | |
|---|---|---|
| C. verum leaf oil | Chlorhexidine digluconate | |
| C. albicans (ATCC MYA-2876) | 2.0 | 1.0 |
| C. tropicalis (ATCC 750) | 2.0 | 4.0 |
| C. dubliniensis (ATCC MYA-646) | 2.0 | 4.0 |
Scanning electron microscopy (SEM) of established biofilms
Ultrastructure of established biofilms of C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 750), and C. dubliniensis (ATCC MYA-646) after treating with 1.0, 2.0, and 4.0 mg/ml of C. verum leaf oil, 1 mg/ml (for C. albicans biofilms), 4.0 mg/ml (for C. tropicalis and C. dubliniensis biofilms) chlorhexidine digluconate and 0.008 mg/ml Fluconazole was qualitatively evaluated by SEM (Figures 4, 5, and 6).
Figure 4.
SEM images of Candida albicans (ATCC MYA-2876) established biofilms after 24 hr treating with 1.0 mg/ml Cinnamomum verum leaf oil (A and D), 2.0 mg/ml C. verum leaf oil (B and E), 4 mg/ml C. verum leaf oil (C and F), 1.0 mg/ml chlorhexidine digluconate (G and J) and 0.008 mg/mL Fluconazole (H and K). I and L: Negative control. Circles- Cell wall deformities with treatments. Red solid arrows- Leakages of intracellular components
Figure 5.
SEM images of Candida tropicalis (ATCC 750) established biofilms after 24 hr treatment with 1.0 mg/ml Cinnamomum verum leaf oil (A and D), 2.0 mg/ml C. verum leaf oil (B and E), 4.0 mg/ml C. verum leaf oil (C and F), 4.0 mg/ml chlorhexidine digluconate (G and J) and 0.008 mg/ml Fluconazole (H and K) I and L: Negative control. Solid circles indicate Cell wall deformities with treatments
Figure 6.
SEM images of Candida dubliniensis (ATCC MYA-646) established biofilms after 24 hr treatment of 1.0 mg/ml Cinnamomum verum leaf oil (A and D), 2.0 mg/ml C. verum leaf oil (B and E), 4.0 mg/ml C. verum leaf oil (C and F), 4.0 mg/ml chlorhexidine digluconate (G and J), and 0.008 mg/ml Fluconazole (H and K) I and L: Negative control. Solid circles-Cell wall deformities with treatments. Solid arrows-Leakages of intracellular components
C. verum leaf oil caused Candida cell shrinkage by damaging walls of mature sessile cells, pseudohyphae, and hyphae and caused leakage of intracellular materials. These effects were concentration-dependent. Maximum cell damage was observed with 4 mg/ml of C. verum leaf oil. Both 2 mg/ml and 4 mg/ml of C. verum leaf oil showed complete destruction of 24 hr mature biofilms of C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 750), and C. dubliniensis (ATCC MYA-646) with 24 hr treatment.
When considering chlorhexidine digluconate, it exhibited a similar effect as C. verum leaf oil (damaging cell walls of Candida cells and causing cytoplasmic leakages) on established Candida biofilms. Similar observations were obtained for 24 hr established biofilms of C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 750), and C. dubliniensis (ATCC MYA-646) with 0.008 mg/ml Fluconazole. Biofilms treated with 0.008 mg/ml Fluconazole exhibited rough cellular surfaces indicating that cell wall deformities and leakages of intracellular components were observed in C. albicans and C. dubliniensis biofilms.
Transmission electron microscopy (TEM)
Post-exposure cellular morphology of planktonic C. albicans (ATCC MYA-2876); C. dubliniensis (ATCC MYA-646), and C. tropicalis (ATCC 750) was determined using TEM.
TEM images of test strains after 24 hr exposure to MIC (1.0 mg/ml) of C. verum leaf oil and chlorhexidine digluconate were obtained as follows (Figure 7): TEM clearly indicates cell wall damages, intracellular granulations, and vacuole formation.
Figure 7.
Transmission Electron Microscopic (TEM) images of Candida albicans (A, B, and C); C. tropicalis (D, E, and F) and C. dubliniensis (G, H, and I). Red solid arrows indicate intra-cellular vacuoles, red circles indicate cell wall damages, and black solid arrows indicate cytoplasmic coarse granular inclusion bodies. C, F, and I are negative controls
In vitro cytotoxicity of C. verum leaf oil (HaCaT human keratinocyte cell line)
Figure 8 shows percentage of growth inhibition after treatment with different concentrations. No significant change in HaCaT cell viability within the 0-1000 mg/ml concentration range of true cinnamon leaf EO or chlorhexidine digluconate was detected. In this experiment, no toxic effect on HaCaT cells was noted with any concentrations of EO tested.
Figure 8.
Post-exposure MTT metabolic activity/viability of HaCaT cell line after 24 hr treatment with different concentrations of Cinnamomum verum leaf oil and chlorhexidine digluconate. All error bars represent the ± 2 standard deviations (SD)
Chemical composition of true cinnamon leaf oil
The most abundant compound of C. verum leaf EO was Eugenol (77.22%). Benzyl benzoate (4.53%), trans caryophyllene (3.39%), acetyle eugenol (2.75%), and linalool (2.11%) were identified as minor components.
Discussion
Cinnamon has been used as a common culinary spice in several communities for centuries. Additionally, cinnamon has been also employed as folk medicine and phytomedicinal alternative in different cultures. The present study was conducted to find out the efficacy of C. verum/ true cinnamon leaf oil as a potential phytomedicinal therapeutic alternative against three commonest infection-causing Candida strains, namely C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 750), and C. dubliniensis (ATCC MYA-646). The results of the present study show that C. verum EO had an important antifungal activity on all the tested strains of Candida.
In the present study, observations obtained from the microatmospheric plate method showed anti-Candida activity of C. verum leaf oil vapor. All three test strains exhibited a zone of growth inhibition with the administration of C. verum oil vapor (Table 1). Since, at normal body temperature, C. verum leaf oil vaporizes, it is important to evaluate the efficacy of an antimicrobial agent when it is not directly in contact with the affected areas. So this step can be considered as a screening test for anti-Candida activity of C. verum EO in its vapor phase.
The MFC/MIC ratio suggests that true cinnamon leaf EO had a fungicidal effect (26) on all three test strains. Though these data, in principle, demonstrate the antifungal action of C. verum leaf oil on planktonic Candida, MIC and MFC values of the current study are slightly different from recently published findings. (27, 28). These differences in MIC and MFC may be due to the concentration variations of active compounds in EO used.
According to the classification of the activity level of plant materials based on MIC value introduced by Duarte et al. (2005), MIC up to 0.5 mg/ml is considered as strong active, concentrations from 0.55 to 1.5 mg/ml are considered as moderately active, and above 1.5 mg/ml are considered as weakly active plant materials against tested microorganisms (29). According to this classification, the results obtained with the EO of C. verum leaves showed moderate antifungal activity on planktonic Candida. On the other hand commercial antifungal chlorhexidine digluconate exhibited a similar anti-Candida action as C. verum leaf oil for C. albicans and C. dubliniensis by demonstrating MIC value of 1 mg/ml (Table 2).
As well as minimum effective concentrations, the time required to completely eradicate/kill the microbial population is one of the key determinants of antimicrobial potency of a given antimicrobial agent and plays a major role in designing the dosage regime of a given antimicrobial drug (30). Results obtained from the killing time assay of C. verum leaf oil on test strain exhibited a concentration-dependent killing time. MFC (2.0 mg/ml) of cinnamon kills C. albicans within 6 hr whereas 2.0 mg/ml chlorhexidine digluconate kills C. albicans within 1 hr (Figure 1). Sub-MFC concentrations of C. verum EO does not exhibit any fungicidal effect within the 24 hr experiment period. Since killing time is concentration-dependent, shorter killing times can be acquired by increasing the concentration of EO, but the toxicological assessments should be contemplated. Though killing time is considered as an essential component of the antimicrobial profile, there is no evidence-based data on time-kill kinetics of C. verum leaf EO on Candida spp. The present study fills this deficiency of available data with an in vitro experimental design performed on ATCC type Candida strains.
In addition to the ability of true cinnamon leaf EO to act on Candida spp. planktonic cells, a strong antifungal potential was detected relative to the 24 hr established Candida biofilms. True cinnamon EO at a concentration of 0.2 mg/ml reduced the viability of C. tropicalis and C. dubliniensis biofilms by at least 50%, except for the C. albicans biofilm, which exhibited a 50% viability reduction with 0.1 mg/ml EO concentration (Table 3). These findings suggest the potential use of C. verum leaf EO as an antifungal for patients affected with chronic candidiasis. Notably, 24 hr exposure of 2 mg/ml EO caused complete killing of mature biofilms of the three types of investigated biofilms (Table 4). Though there are few studies in the literature on the antimicrobial effect of C. verum leaf EO, no published study assessed its action on Candida spp. biofilms.
SEM images were taken to understand the structure of biofilms after subjecting to EO chemical stress. All biofilms of test strains exhibited cell wall damages, cell wall deformities, and leakages of intracellular materials with treatment of C. verum leaf oil (Figures 4, 5, and 6). Importantly, scanning electron microscopy confirmed the dose-dependent nature of the effects of cinnamon leaf EO. Fluconazole is a known antifungal agent which belongs to the azole group and inhibits synthesis of fungal sterol, ergosterol (20). On the other hand, chlorhexidine is a biguanide that is used as an antibacterial mouth rinse. It alters the morphology of cells, damages the cell wall of microorganisms, and releases intracellular components. It has been suggested as a well-known therapeutic antifungal agent for oral candidiasis (31, 32). Since both antimicrobial agents have an effect on Candida cell wall, the ultrastructure of established Candida biofilms with MBEC of chlorhexidine digluconate and 0.008 mg/ml Fluconazole (maximum recommended in vitro assay concentration, CLSI) was also visualized. The intensity of the post-exposure response of Fluconazole was minimal due to low concentration.
To confirm the SEM observations, and to evaluate the intracellular/morphological changes of unicellular yeast forms, TEM images of C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 750), and C. dubliniensis (ATCC MYA-646) test strains were taken after treatment with MIC of C. verum oil. TEM images showed cell wall damages and leakages of the intracellular compartment (Figure 7). Importantly, TEM images revealed post-exposure cytoplasmic changes including intracellular vacuoles formation, scattered cytoplasm, and formation of cytoplasmic granular inclusion bodies. These changes are suggestive of chemical stress on Candida cells by C. verum leaf oil.
The toxicity of true cinnamon EO on host tissues was evaluated using an in vitro cell culture model of the human non-cancer keratinocytes (HaCaT) cell line. Toxicology assessments provide proper understanding of effective, nontoxic dose and help in dose regimen designing by integrating both pharmacodynamics and pharmacokinetics of C. verum leaf oil. Furthermore, there is a lack of published data on toxicology studies of C. verum leaf oil and the current study fills that deficiency. The maximum concentration tested in this study was 1000 mg/ml (neat concentration of true cinnamon leaf EO oil) and none of the tested concentrations showed any inhibitory effect on HaCaT cells (Figure 8). This finding indicates the safe use of C. verum leaf EO up to 1000 mg/ml without any toxic effect on human cells.
Based on in vitro toxicology study results and pharmacodynamics of C. verum leaf oil on Candida sessile and planktonic cells, true cinnamon leaf EO can be considered a potential therapeutic alternative for Candida infections. Also, the authors suggest future research on the effect of C. verum leaf EO on a wide range of pathogenic fungi and bacteria.
The results of the chemical analysis of the true cinnamon leaf EO agree with the findings by previous authors, which indicate that eugenol is its most abundant chemical component (77.22%) (33, 34) whereas the other chemical compounds appear in smaller concentrations.
According to available data, a similar mode of antifungal action of both cinnamon leaf oil and chlorhexidine digluconate was noted. Lipophilic eugenol can interfere with cell wall integrity and fluidity as well as biofilm extracellular matrix by actively penetrating the phospholipid bilayer of the cell membrane and ultimately disrupting it (35).
Conclusion
The EO extracted from C. verum leaves contains eugenol as its major chemical component. It possess an antifungal action on Candida spp. planktonic cells and biofilm by acting on the cell wall integrity. Moreover, it does not have any toxic effect on human keratinocytes.
Acknowledgment
The results described in this paper were part of the thesis presented by Gayan Kanchana Wijesinghe, to the Piracicaba Dental School of the State University of Campinas in partial fulfillment of the requirements for the degree of Master in Oral and Dental Biology, in Microbiology and Immunology area. This work was supported by the National Council for Scientific and Technological Development (CNPq) (grant numbers 132718/2018-9). This paper is dedicated to the memory of Prof. Rafael Nóbrega Stipp.
Statement of Ethics
No human or animal experiments were performed in this research.
Author Contributions
GK-Conception or design of the work, data collection, data analysis, and interpretation, drafting the article, critical revision of the article, final approval of the version to be published; FC-data collection, final approval of the version to be published; TR and SN-conception or design of the work, data collection, data analysis and interpretation, final approval of the version to be published; FJ, JP, GC, JD, and PL-data collection, final approval of the version to be published; JF-conception or design of the work, data collection, data analysis, and interpretation, drafting the article, critical revision of the article, final approval of the version to be published.
Conflicts of Interest
The authors have no conflicts of interest to declare.
References
- 1.Wijesinghe GK, Maia FC, de Oliveira TR, de Feiria SNB, Joia F, Barbosa JP, et al. Effect of Cinnamomum verum leaf essential oil on virulence factors of Candida species and determination of the in-vivo toxicity with Galleria mellonella model. Mem Inst Oswaldo Cruz. 2020;115:e200349. doi: 10.1590/0074-02760200349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Oliveira T, Teixeira A, Barbosa JP, de Feiria SNB, Boni GC, Maia F, et al. Melaleuca spp. essential oil and its medical applicability. A Brief Review. Braz J Nat Sci. 2020;3:249. [Google Scholar]
- 3.Wijesinghe G, Jayarathna P, Gunasekara T, Fernando N, Kottegoda N, Weerasekera M. Antibacterial and anti-Candida activity of chlorhexidine gluconate, Triphala and Munamal pothu (bark of Mimusops elengi) Sri Lankan Journal of Infectious Diseases. 2018;8:25–31. [Google Scholar]
- 4.Gupta P, Daswani P, Birdi T. Approaches in fostering quality parameters for medicinal botanicals in the Indian context. Indian J Pharmacol. 2014;46:363–371. doi: 10.4103/0253-7613.135946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ranasinghe P, Pigera S, Premakumara GS, Galappaththy P, Constantine GR, Katulanda P. Medicinal properties of “true” cinnamon (Cinnamomum zeylanicum): a systematic review. BMC Complement Altern Med. 2013;13:275. doi: 10.1186/1472-6882-13-275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Wijesinghe GK, Dilhari A, Gayani B, Kottegoda N, Samaranayake L, Weerasekera M. Influence of Laboratory Culture Media on In-vitro Growth, Adhesion and Biofilm Formation of Pseudomonas aeruginosa and Staphylococcus aureus. Med Princ Pract. 2019;28:28–35. doi: 10.1159/000494757. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Acker HA, Van DP, Coenye P. Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends Microbiol. 2014;22:326–333. doi: 10.1016/j.tim.2014.02.001. [DOI] [PubMed] [Google Scholar]
- 8.Deveau A, Hogan DA. Linking Quorum Sensing Regulation and Biofilm Formation by Candida albicans. Methods Mol Biol. 2011;692:219–233. doi: 10.1007/978-1-60761-971-0_16. [DOI] [PubMed] [Google Scholar]
- 9.Percival SL, Suleman L, Vuotto C, Donelli G. Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control. J Med Microbiol. 2015;64:323–334. doi: 10.1099/jmm.0.000032. [DOI] [PubMed] [Google Scholar]
- 10.Weerasekera MM, Wijesinghe GK, Jayarathna TA, Gunasekara CP, Fernando N, Kottegoda N, et al. Culture media profoundly affect Candida albicans and Candida tropicalis growth, adhesion, and biofilm development. Mem Inst Oswaldo Cruz. 2016;111:697–702. doi: 10.1590/0074-02760160294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Nett JE. Future directions for anti-biofilm therapeutics targeting Candida. Expert Rev Anti Infect Ther. 2014;12:375–382. doi: 10.1586/14787210.2014.885838. [DOI] [PubMed] [Google Scholar]
- 12.Lazar V, Ditu LM, Curutiu C, Gheorghe I, Holban A, Popa M, et al. Periodontitis: A Useful Reference; Arjunan. London, UK, : InTech Open; 2017. Impact of dental plaque biofilms in periodontal disease: Management and future therapy; pp. 11–42. [Google Scholar]
- 13.Nomura R, Nakano K, Nemoto H, Fujita K, Inagaki S, Takahashi T, et al. Isolation and characterization of Streptococcus mutans in heart valve and dental plaque specimens from a patient with infective endocarditis. J Med Microbiol. 2006;55:1135–1140. doi: 10.1099/jmm.0.46609-0. [DOI] [PubMed] [Google Scholar]
- 14.Maia FC, Wijesinghe GK, Oliveira TR, Barbosa JP, de Feiria SNB, Boni GC, et al. Phyllanthus niruri L (stone breacher) as an alternative of anti-human diseases, antimicrobial agent, and its applicability to combat resistant microrganisms A brief review. Braz J Nat Sci. 2020;3:342–353. [Google Scholar]
- 15.Spampinato C, Leonardi D. Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents. Biomed Res Int. 2013;2013:204237. doi: 10.1155/2013/204237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.de Oliveira Santos GC, Vasconcelos CC, Lopes AJO, de Sousa Cartágenes MdS, Filho AKDB, do Nascimento FRF, et al. Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents. Front Microbiol. 2018;9:1351. doi: 10.3389/fmicb.2018.01351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wijesinghe GK. Effect of True Cinnamon (Cinnamomum verum) Leaf Oil Against In VitroCandida Biofilms and Its Cytotoxic Effect. Master’s Thesis. State university of Campinas, Brazil. 2019. Available from: http://repositorio.unicamp.br/jspui/bitstream/REPOSIP/335816/1/Wijesinghe_GayanKanchana_M.pdf.
- 18.Serban ES, Ionescu M, Matinca D, Maier CS, Bojiţă MT. Screening of the antibacterial and antifungal activity of eight volatile essential oils. Farmacia. 2011;59:440–46. [Google Scholar]
- 19.CLSI. Performance Standards for Antifungal Susceptibility Testing of yeasts. 1st ed. CLSI Supplement M60. Wayne. PA: Clinical and Laboratory Standards Institute; 2017. [Google Scholar]
- 20.Khodavandi A, Alizadeh F, Vanda NA, Karimi G, Chong PP. Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine against Candidaalbicans. Pharm Biol. 2014;52:1505–1509. doi: 10.3109/13880209.2014.900808. [DOI] [PubMed] [Google Scholar]
- 21.Souza CMC, Junior SAP, Moraes TDS, Damasceno JL, Mendes SA, Dias HJ, et al. Antifungal activity of plant-derived essential oils on Candida tropicalis planktonic and biofilms cells. Med Mycol. 2016;54:515–523. doi: 10.1093/mmy/myw003. [DOI] [PubMed] [Google Scholar]
- 22.Gayani B, Dilhari A, Wijesinghe GK, Kumarage S, Abayaweera G, Samarakoon SR, et al. Effect of natural curcuminoids-intercalated layered double hydroxide nanohybrid against Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis: A bactericidal, antibiofilm, and mechanistic study. Microbiologyopen. 2019;8:e00723. doi: 10.1002/mbo3.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Kapoor G, Saigal S, Elongavan A. Action and Resistance Mechanisms of Antibiotics: A Guide for Clinicians. J Anaesthesiol Clin Pharmacol. 2017;33:300–305. doi: 10.4103/joacp.JOACP_349_15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Zanette C, Pelin M, Crosera M, Adami G, Bovenzi M, Larese FF, et al. Silver nanoparticles exert a long-lasting antiproliferative effect on human keratinocyte HaCaT cell line. Toxicology in Vitro. 2011;25:1053–1060. doi: 10.1016/j.tiv.2011.04.005. [DOI] [PubMed] [Google Scholar]
- 25.Tantengco OAG, Jacinto SD. Cytotoxic activity of crude extracts and fractions from Premna odorata (Blanco) Artocarpus camansi (Blanco) and Gliricidia sepium (Jacq ) against selected human cancer cell lines. Asian Pac J Trop Biomed. 2015;5:1037–1041. [Google Scholar]
- 26.Siddiqui ZN, Farooq F, Musthafa TNM, Ahmad A, Khan AU. Synthesis, characterization and antimicrobial evaluation of novel halopyrazole derivatives. Journal of Saudi Chemical Society. 2013;17:237–43. [Google Scholar]
- 27.Castro RD, Lima EO. Anti-Candida activity and chemical composition of Cinnamomum zeylanicum blume essential oil. Braz Arch Biol Technol. 2013;56:749–55. [Google Scholar]
- 28.Rangel MDL, Aquino SGD, Lima JMD Castellano LR, de Castro RD. In vitro effect of Cinnamomum zeylanicum blume essential oil on Candida spp involved in oral infections. Evid based Complement Alternat Med. 2018;2018:4045013. doi: 10.1155/2018/4045013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Duarte MC, Figueira GM, Sartoratto Um, Rehder VLG, Delarmelina C. Anti-Candida activity of Brazilian medicinal plants. J Ethnopharmacol. 2005;97:305–311. doi: 10.1016/j.jep.2004.11.016. [DOI] [PubMed] [Google Scholar]
- 30.Bax HI, Bakker-Woudenberg IAJM, de Vogel CP, van der Meijden A, Verbon A, de Steenwinkel JEM. The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs. Tuberculosis. 2017;105:80–85. doi: 10.1016/j.tube.2017.04.010. [DOI] [PubMed] [Google Scholar]
- 31.Da Silva PMB, Acosta EJTR, de Rezende Pinto L, Graeff M, Spolidorio DMP, Almeida RS, et al. Microscopical analysis of Candida albicans biofilms on heat-polymerised acrylic resin after chlorhexidine gluconate and sodium hypochlorite treatments. Mycoses. 2011;54:e712–e717. doi: 10.1111/j.1439-0507.2010.02005.x. [DOI] [PubMed] [Google Scholar]
- 32.Scheibler E, da Silva RM, Leite CE, Campos MM, Figueiredo MA, Salum FG, et al. Stability and efficacy of combined nystatin and chlorhexidine against suspensions and biofilms of Candida albicans. Archives of Oral Biology. 2018;89:70–76. doi: 10.1016/j.archoralbio.2018.02.009. [DOI] [PubMed] [Google Scholar]
- 33.Jantan IB, Karim Moharam BA, Santhanam J. Jamal JA. Correlation between Chemical Composition and Antifungal Activity of the Essential Oils of Eight Cinnamomum Species. Pharm Biol. 2008;46:406–412. [Google Scholar]
- 34.Choi O, Cho SK, Kim J, Park CG, Kim J. In vitro antibacterial activity and major bioactive components of Cinnamomum verum essential oils against cariogenic bacteria, Streptococcus mutans and Streptococcus sobrinus. Asian Pacific Journal of Tropical Biomedicine. 2016;6:308–314. [Google Scholar]
- 35.Pavesi C, Banks LA, Hudaib T. Antifungal and antibacterial activities of eugenol and non-polar extract of Syzygium aromaticum L. J Pharma Sci Res. 2018;10:337–339. [Google Scholar]